Pacing for Carotid Sinus Syndrome and Sick Sinus Syndrome

BRIGNOLE, M., ET AL: Pacing for Carotid Sinus Syndrome and Sick Sinus Syndrome. The real incidence of pacemaker implants for carotid sinus syndrome (CSS) and the relation between CSS and sick sinus syndrome (SSS) is not precisely known. Patients who needed pacing therapy because of atrial bradyarrhythmias were investigated by means of carotid sinus massage, dynamic ECG, and invasive electrophysiological sinus node evaluation. Of 298 consecutive patients receiving a pacemaker implant, 36 (12%) had a severe cardioinhibitory carotid sinus reflex with reproducible spontaneous symptoms (CSS), 33 (11%) had sinus bradycardia < 50 beat/min or an abnormal electrophysiological evaluation (SSS) and 24 (8%) had both (CSS + SSS). The annual incidence was 40, 37, and 26, respectively, implants per year/million of inhabitants (total incidence 325). Patients affected by CSS, if compared with those affected by SSS, showed: a higher prevalence of syncope (97% vs 42%); more syncopal, episodes per patient (2.9 ± 2 vs 1.8 ± 0.9); a lower prevalence of associated cardiac diseases (53% vs 100%); cardiac enlargement (36% vs 88%); heart failure (6% vs 36%) and paroxysmal atrial fibrillation (0% vs 42%); and a more frequent indication for VVI pacing (75% vs 3%). In patients with CSS + SSS, intermediate characteristics were present. In conclusion, CSS is as frequent an indication to cardiac pacing as SSS; clinical differences justify a distinction between them, even if they are associated in 26% of cases.     

Carotid Sinus Syndrome: Acute Hemodynamic Evaluation of a Dual Chamber Pacing Mode

Cardiac pacing is the treatment of choice in patients with carotid sinus syndrome (CSS), Three different pacing modes were tested in 20 patients (16 males, 4 females; mean age 75 ± 9 years) with documented symptomatic CSS, Three carotid sinus massages (CSM) were performed in each supine patient successively paced in random order in: DDI—the reference pacing mode; DDD—automatic mode conversion (DDD/AMC) allowing automatic switching from AAI to DDD when AV block occurs; DDD/AMC plus a trial acceleration (DDD/AMC + ace); and OOO (CSM without pacing) to determine whether the vasodepressive effect was still present 10 minutes after the preceding CSM. Intraarterial blood pressure was continuously monitored. Results were expressed as the value of the mean systolic BP at TO + 3 s + 6 s … TO + 30 s divided by the value of the mean systolic blood pressure prior to onset of CSM. The drop in arterial blood pressure was more severe in the DDI mode than in DDD/AMC (P < 0,001) and DDD/AMC + acc (P < 0.0001) in 20 patients. In the OOO mode, the drop in arterial blood pressure was most marked and greater than in the DDI mode (P < 0.0001). The average time between start of the CSM and onset of the drop in blood pressure was the same in the three dual chamber modes. We conclude that the DDD/AMC mode significantly improves the vasodepressor response to CSM compared to the DDI mode. There is a current trend favoring DDD/AMC + acc over DDD/AMC.     

Is DDD Superior to VVI Pacing in Mixed Carotid Sinus Syndrome? An Acute and Medium-Term Study

The aim of this study was to evaluate fhe importance of atrial synchronism for pacing therapy of patients with mixed carotid sinus syndrome. In 23 patients (21 m, two f: mean age 69 ± 8 years) affected by symptomatic mixed carotid sinus syndrome we performed: (1) Research of ventriculo-atrial conduction, orthostatic hypotension and pacemaker effect; and [2] Carotid sinus massage in the standing position during VVI and DVI temporary pacing. Next, ail patients received a permanent DDD pacemaker and entered a 2 month two period single-blind, randomized, cross-over study on DVI/DDD versus VVI mode. During the DVI/DDD period, no syncope occurred in any patients, minor symptoms persisted in 11 (48%) of them; during VVI period syncopes recurred in three patients, symptoms requiring the withdrawal of VVI pacing and premature DVI/DDD reprogramming in eight patients, minor symptoms in 17 (74%). A comparison between 14 patients, who preferred DVI/DDD period (Group A), and the remaining nine patients who noted no preference between DVI/DDD and VVI period (Group B) was performed on the basis of the preimplant evaluation. Group A patients had a greater pacemaker effect (-34 ± 16 mmHg vs -16 ± 14 mmHg) and a higher prevalence of symptomatic pacemaker effect (50% vs 0%), of ventriculo-atrial conduction (78% vs 44%) and of orthostatic hypotension (50% vs 11%), while the entity of the systolic pressure fall caused by carotid sinus massage was similar in the two groups either during VVI mode (Group A-51 ± 16 mmHg vs Group B-56 ± 27 mmHg) or DVI mode (Group A-38 ± 17 mmHg vs Group 3–45 ± 17 mmHg). Thus, we conclude that vasodepressor reflex of carotid sinus syndrome is not prevented by DVI/DDD pacing even if the loss of atrial synchronism resulting from WI pacing, by adding an important pacemaker effect, causes a more severe hemodynamic consequence. DVI/DDD pacing is more effective than VVI in 61% of patients. When pacemaker effect, ventriculoatrial conduction and orthostatic hypotension are present, VVI failure is possible, therefore DVI/DDD stimulation is indicated; on the contrary the evaluation of the vasodepressor reflex during WJ or DVI temporary pacing is of little value in the choice of the mode of pacing.     

The Role of Rate Hysteresis Pacing in the Hypersensitive Carotid Sinus Syndrome

The ability of rate hysteresis programming with the escape interval longer than the automatic interval lo reduce the hypotensive response to carotid sinus massage at the onset of ventricular pacing was studied in six patients paced for carotid sinus syndrome. Rate hysteresis significantly reduced this hypotensive response and abolished spontaneous symptoms in two patients and symptoms reproduced by carotid sinus massage in four patients.     

The Role of Rate Hysteresis Pacing in the Hypersensitive Carotid Sinus Syndrome

The ability of rate hysteresis programming with the escape interval longer than the automatic interval lo reduce the hypotensive response to carotid sinus massage at the onset of ventricular pacing was studied in six patients paced for carotid sinus syndrome. Rate hysteresis significantly reduced this hypotensive response and abolished spontaneous symptoms in two patients and symptoms reproduced by carotid sinus massage in four patients.     

Validation of a Method for Choice of Pacing Mode in Carotid Sinus Syndrome With or Without Sinus Bradycardia

A new method for selection of the pacing mode in 60 consecutive patients with severe cardie-inhibitory or mixed carotid sinus syndrome was prospectively validated. ODD pacing was preferred for 26 patients with: (1) the cardioinhibitory form and who had symptomatic pacemaker effect; (2) mixed type I form, (cardioinhibitory and vasodepressor) with symptomatic pacemaker effect, ventriculoatrial conduction or orthostatic hypotension; (3) mixed type II; or (4) severe bradycardia. VVI pacing was seiected in the remaining 34 patients without these symptoms. During a 32 ± 10 month follow-up period syncope and severe dizziness persisted in five patients in the VVI group (15%) and in three patients in the ODD group (12%). Symptomatic relief occurred in 87% (52/60) of patients. Minor symptoms persisted in 47% of the VVI group and 42% of the DDD group. No patient developed cardiac insufficiency or intolerance to pacing. During a 2-month duration a single-blind, randomized, cross-over study compared VVI and DDD pacing, 69% of the patients programmed from DDD to VVI suffered more frequent, severe, and intolerable symptoms. (1) Thirty four of 60 patients (57% of the entire group) in whom VVI pacing was satisfactory were identified prior to pacemaker implant. In the remainder, VVI pacing was contraindicated as it produced frequent side effects. (2) The preimplant predictive value that VVI pacing would be successful was 85% for those eventually receiving VVI pacemakers and the preimplant predictive value that VVI pacing would fail was 69% for those who underwent DDD implant.     

Clinical Experience with Thera DR Rate-Drop Response Pacing Algorithm in Carotid Sinus Syndrome and Vasovagal Syncope

This study examined the effectiveness of cardiac pacing using the Thera DR rate-drop response algorithm for prevention of recurrent symptoms in patients with carotid sinus syndrome (CSS) or vasovagal syncope. The algorithm comprises both diagnostic and treatment elements. The diagnostic element consists of a programmable "window" used to identify heart rate changes compatible with an evolving neurally mediated syncopal episode. The treatment arm consists of pacing at a selectable rate and for a programmable duration. Forty-three patients (mean age 53 ± 20.4 years) with CSS alone (n = 8), CSS in conjunction with vasovagal syncope (n = 4), or vasovagal syncope alone (n = 31) were included. Thirty-nine had recurrent syncope, while the remaining four reported multiple presyncopal events. Prior to pacing, 40 ± 152 syncopal episodes (range from 1 to approximately 1,000 syncopal events) over the preceding 56 ± 84.5 months. Postpacing follow-up duration was 204 ± 172 days. Three patients have been lost to follow-up and in one patient the algorithm was disabled. Among the remaining 39 individuals, 31 (80%) indicated absence or diminished frequency of symptoms, or less severe symptoms. Twenty-three patients (23/29, or 59%) were asymptomatic with respect to syncope or presyncope. Sixteen patients had symptom recurrences. Of these, seven experienced syncope (7/39, or 18%) and 9 (29%) had presyncope: the majority of patients with recurrences (6/7 syncope and 7/9 presyncope) were individuals with a history of vasovagal syncope. Consequently, although symptoms were observed during postpacing follow-up, they appeared to be of reduced frequency and severity. Thus, our findings suggest that a transient period of high rate pacing triggered by the Thera DR rate-drop response algorithm was beneficial in a large proportion of highly symptomatic patients with CSS or vasovagal syncope.     

Improved Dual Chamber Pacing Mode in Paroxysmal Atrioventricular Conduction Disorders

GIRODO, S., ET AL.: Improved Dual Chamber Pacing Mode in Paroxysmal Atrioventricular Conduction Disorders. Dual chamber pacing may sometimes be directly indicated for carotid sinus hypersensitivity, vasovagal syndrome, and certain cases of sinoatrial block and intermittent atrioventricular (AV) block, although AV conduction is dominantly normal. At times of normal AV conduction, competition between ventricular pacing and spontaneous ventricular depolarization may occur, with its adverse hemodynamic effects on ventricular function and unnecessary drainage of pacemaker battery energy. A new mode of stimulation is described, called automatic DDD mode, which functions in 'pseudo-AAI' mode during normal AV conduction and reverts to classical DDD function during episodes of AV blocks. Furthermore, during pseudo-AAI function, the pacemaker measures certain physiological parameters that serve to automatically program certain parameters used in DDD mode. Preliminary clinical evaluation has shown that this new mode functions satisfactorily.     

Assessment of VVI Diagnostic Pacing Mode in Patients with Cardioinhibitory Carotid Sinus Syndrome

In this study, we used Holter pacemakers in a group of 13 patients affected by severe carotid sinus syndrome in order to evaluate its evolution. All the patients had one to three syncopal episodes and frequent other symptoms such as fainting, dizziness, lightheadedness and pre-syncope interferring with their daily activity so that pacemaker therapy was considered necessary. Patient selection criteria were: presence of the isolated cardioinhibitory type, absence of associated sinus dysfunction and absence of symptomatic WI pacemaker effect. All the patients received a Micropacer 1 device; among special functions, bradycardia events counter was activated and programmed so that each sequence of three consecutives beats at a cycle length 1.5 sec (i.e., 4.5 sec total interval) could he recognized and stored in its memory. The follow-up lasted 13±7 months. Brady events occurred in eight out of 13 patients (62%), during this period. Syncope and major symptoms disappeared in ail the patients; mild dizziness recurred rarely in two patients and were not linked to brady-events recording. In conclusion, disappearance of severe symptoms observed after pacemaker implant in cardioinhibitory carotid sinus syndrome seems to depend from pacing therapy, in most cases, yet from the benign natural course of the disease in some other cases.     

Electrophysiologic Findings in Carotid Sinus Massage

Thirty patients with carotid sinus syndrome were electrophysiologically studied. In 14 patients carotid sinus massage was performed during atrial and ventricular stimulation, and the conduction times were measured. The AH-time was prolonged by more than 120ms in 6 patients(20%); the HV-time was prolonged in 6 patients by more than 55 ms (20%); 5 patients had bundle branch block (16.7%); The sinus node recovery time was prolonged in 7 out of 27 patients (26%). Ten patients (33%) did not have additional electrophysiologic abnormalities. There was a predominance of carotid sinus syndrome on the right side. During carotid sinus massage there was a significant increase of the AH-time, but there were no significant changes of the HV-time or the width of the QRS-complexes. Twenty-one patients developed an atrial asystole and 9 patients an atrial bradycardia and an additional AV-block. There was a longer AH-time and a longer prolongation of the AH-time in the patients who developed an AV-block. Twelve out of 14 patients (85.7%) developed an AV-block during carotid sinus massage and atrial pacing. During ventricular pacing 5 of 14 patients (35.7%) revealed a complete retrograde block before carotid sinus massage and 5 of the remaining 9 patients developed a total retrograde block during carotid sinus massage. Consequently, in 71.4% of the patients with carotid sinus syndrome complete retrograde conduction block and atrial asystole can be expected during attacks of ventricular asystole and simultaneous ventricular pacing. In conclusion, there is a high incidence of additional disturbances of the sinus node function and AV-conduction in patients with carotid sinus syndrome. AAI pacemakers are contraindicateddue to the common development of additional A V-block during carotid sinus massage. Physiologic pacing might contribute to better hemodynamics, particularly in patients with the mixed type of carotid sinus syndrome.     

Ventricular Pacing as the Preferable Mode for Long-Term Pacing in Patients with Carotid Sinus Syncope of the Cardioinhibitory Type

This study was designed to determine the efficacy of long-term VVI pacing in patients having the isolated cardioinhibitory type of carotid sinus syncope. The study included 20 patients suffering from repeated syncopal attacks; all were proven by electrophysiological studies to have isolated forms of cardioinhibitory type carotid sinus syncope. Long-term pacing by the VVI mode was carried out in all patients by programming the pacemaker rate well below the patient's sinus rate. The follow-up period after pacemaker implantation, which ranged from 2 to 54 months (average, 20 months), revealed that none of the patients had any recurrence of syncopal attack. Repeated Holter monitoring showed that ten had permanent sinus rhythm without any artificial pacing activity, while in the other ten, pacemaker activity was recorded--predominant in two patients and rare in the other eight. During Holter monitoring, attacks of weakness were reported by four patients; however, they were not related to pacemaker activity. This report indicates the importance of electrophysiological studies in patients suffering from carotid sinus syncope. These studies make possible the diagnosis of the isolated form of cardioinhibitory type syncope for which VVI pacing offers complete relief of symptomatology, thus rendering AV sequential pacing superfluous.     

Carotid Sinus Hypersensitivity and Syndrome in Patients with Chronic Atrial Fibrillation

Carotid sinus hypersensitivity (CSH) has been studied in subjects in sinus rhythm, but it has never been studied in patients with chronic atrial fibrillation (AF). After a finding of CSH in a patient with chronic AF and syncope, we studied the effects of carotid sinus stimulation in a group of patients with AF. Ten patients with chronic AF and normal ventricular rates who complained of dizziness or loss of consciousness underwent right and left carotid sinus massage (CSM) during ECG monitoring. A control group of ten patients with AF but without neurological symptoms was likewise investigated. CSH was present in eight symptomatic patients (5 patients presented right CSH, 1 left and 2 bilateral CSH), but only in three of the control patients. The mean duration of asystole induced by right CSM was 5.94 ± 2.10 seconds; the mean asystolic interval induced by left CSM lasted 8.58 ± 1.42 seconds. Six patients in the symptomatic group had a recurrence of spontaneous symptomatology during CSM, so that a diagnosis of carotid sinus syndrome was established. All symptomatic patients (8 patients with CSH, 2 patients with ventricular standstills but without CSH) received a permanent ventricular pacemaker. Following pacing, all patients, except for one with a significant drop of systolic blood pressure during CSM. became completely asymptomatic. In elder patients with chronic AF, CSH can induce prolonged ventricular asystole, which may be responsible for neurological symptoms such as dizziness, presyncope, or syncope, as observed in patients in sinus rhythm with carotid sinus syndrome. Abnormal sensitivity of the carotid sinus could, therefore, be one of the causes of increased morbidity and mortality in patients with chronic AF. Permanent ventricular pacing may help reduce these complications.     

An Unusual Cause of Carotid Sinus Syndrome: Multiple Symmetric Lipomatosis

A 45-year-old man with multiple symmetric lipomatosis suffered recurrent syncope attributed to carotid sinus syndrome caused by extrinsic compression of the carotid body by the lipomatous masses. Surgical removal reduced but did not stop syncope, which was then controlled by implantation of a DDD pacemaker.     

Hemodynamic Findings During Sinus Rhythm, Atrial and AV Sequential Pacing Compared to Ventricular Pacing In a Dog Model

The hemodynamic responses of atrial lAF], atrioventricu-lar sequential (AVP) and ventricuJar pacing (VP) were compared to sinus rhythm (SfiJ in seventeen anesthetized dogs with intact AV conduction. The atrium and/or ventricle were paced at fixed rates above the control sinus rate. An AV interval shorter than normal conduction was selected to capture the ventricle. The changes of pulmonary capillary wedge pressure (PCWP, mmHg). mean aortic pressure (MAP, mmHg), cardiac output (CO, L/min), systemic vascular resistance (SVR, dynes/s/cm⁻⁵), left ventricular stroke work index (SWI) and mean systolic ejection rate (MSER, ml/s) during sinus rhythm, atrial pacing and atrio-ventricular sequential pacing (expressed in percentages of the individual values during ventricular pacing) were:
The importance of atrial systole for cardiac performance was clearly demonstrated in dogs with normally compliant hearts. In both atrial and atrioventricular sequential pacing compared to ventricular pacing there was a reduction of pulmonary capillary wedge pressure (PCWP) (p < 0.01) and systemic vascular resistance (SVR) (p < 0.01) despite an increase in cardiac output (CO). The lesser mean systolic ejection rate (MSER) found during atrioventricular sequential pacing compared to sinus rhythm and atrial pacing may be explained by the abnormal ventricular depolarization in this pacing mode; nevertheless, the mean systolic ejection rate was still greater than that found during ventricular pacing (p < 0.05).     

Is Chronic Atrial Stimulation a Reliable Method for Single Chamber Pacing in Sick Sinus Syndrome?

To evaluate the feasibility of chronic atrial pacing (AAI) in sick sinus syndrome (SSS), 22 patients (pts) with bradytachycardia syndrome (BTS) and 17 patients with only bradyarrhythmias (BA) were studied on the incidence of supraventricular tachycardias (SVT) and occurring AV block. A scoring system based on symptoms of SVT was developed (grade 0–5). All patients had proven normal AV conduction before PM implantation. In the BTS-group, nine patients (41%) had symptomatic SVT at the end of follow-up (mean 53 months), despite drug therapy. These patients had a high SVT score on entry (mean 3.2). High degree AV block occurred in three patients. Although in the BA-group SVT arose in six patients (35%), there was only one symptomatic patient at the end of follow-up (mean 36 months). In this group, only one patient developed high degree AV block. Atrial stimulation should be considered as a reliable therapy in patients with SSS and low SVT score before PM implantation when normal AV conduction is present.     

Thyrotoxicosis Induced Sick Sinus Syndrome: Medical Therapy May Avoid Permanent Pacing

A 65-year-old white female developed sick sinus syndrome associated with thyrotoxicosis which resolved upon achieving a euthyroid state, thus obviating the need for permanent pacemaker implantation. TSH was less than 0.1 ng/dL, and 24-hour iodine uptake was 28%. After correction of the hyperthyroid state with propylthiouracil and potassium iodine, sinoatrial pauses up to 6 seconds resolved over 10 days. A subsequent sinus node recovery time was normal and no symptoms recurred over 22 months.     

Long-Term Follow-Up of Patients Treated with VVI Pacing and Sequential Pacing with Special Reference to VA Retrograde Conduction

The aim of this prospective study is comparing long-term prognosis in patients implanted with a WI pacemaker (group A) with those implanted with a sequential pacing device, AAI or DDD, (group B). Both groups of 45 patients each, were comparable as regards to age, sex, pacing indications, underlying heart disease, and technical conditions of implantation and were followed-up over 55 months. Atrial arrhythmias (A.A.) incidence was higher in group A: 24. 4% than group B: 8.8% (P < 0.05). Arterial embolisms (A.E.) occurred in group A patients only. Worsening or occurrence of exercise limitation was more frequent in group A: 35.6% as compared to group B: 13.3% (P < 0.05) and deaths related to these complications, occurred in seven cases in group A versus four cases in group B. In group A, all patients who experienced a worsening or occurrence of an A.A. or an A.E., had a ventriculoatrial condLction (VAC). No statistical difference was observed in worsening or occurrence of exercise limitation between patients with VAC and those without VAC: nine (42.8%) and seven (29.2%) but they respectively experienced at least one complication in 16 cases (76.2%) and seven cases (29.2%) (P < 0.01). In conclusion, Jong-term prognosis in patients implanted with VVI pacing as compared to patients implanted with sequential pacing is poorer. The presence of VAC in patients treated with permanent WI pacing is a major factor for complications and deaths related to A.E. and cardiac failure. Thus WI pacing should be avoided in patients with VAC.     

心室起搏管理对病态窦房结综合征患者心功能的影响

目的：观察心室起搏管理（managed ventricular pacing,MVP）对病态窦房结综合征（sick sinus syndrome,SSS）患者心功能的影响.方法：42例植入具有MVP功能的双腔起搏器（Medtronic Adapta ADD01/ADDR01/ADDRL1）的SSS患者,先以双腔起搏（DDD/R）模式工作6个月,再程控为MVP模式工作6个月,统计两种模式下右心室起搏比例,并比较两种模式下患者心功能的变化.结果：在DDD/R模式下,平均右心室心尖部起搏比例达43.6％,左心室射血分数（left ventricular ejection fraction,LVEF）从（56.5±2.6）％下降至（54.1±3.0）％（P=0.001）,左心室舒张末期直径（left ventricular end-diastolic diameter,LVEDD）从（49.6±2.6）mm升高至（51.4±2.4）mm（P=0.002）,B型利钠肽（B-type natriuretic peptide,BNP）从（77.0±16.2） pg/mL升高至（87.2±16.4） pg/mL（P=0.032）.在MVP模式下,平均右心室心尖部起搏比例仅为1.8％,LVEF从（54.1±3.0）％上升至（55.4±1.4）％（P=0.042）,LVEDD从（51.4±2.4）mm下降至（50.2±2.0）mm（P=0.016）,BNP从（87.2±16.4） pg/mL下降至（86.5±14.9） pg/mL（P=0.852）.另外,DDD/R模式下有4例患者发生阵发性心房颤动,而MVP模式下仅1例发生阵发性心房颤动,但差异无统计学意义（P=0.180）.结论：与DDD/R模式比较,MVP模式能显著减少右心室起搏比例,且对心功能有较好的保护作用.     

The Use of Serotonin Reuptake Inhibitors for the Treatment of Recurrent Syncope Due to Carotid Sinus Hypersensitivity Unresponsive to Dual Chamber Cardiac Pacing

Carotid sinus hypersensitivity can be a cause of recurrent unexplained syncope in the older patient. Dual chamber cardiac pacing may relieve the bradycardia, but may not affect the vasodilatory component of this disorder. We report on two patients with carotid sinus hypersensitivity with a predominant vasodilatory component who experienced recurrent syncope following permanent pacemaker implantation. Both patients were treated with serotonin reuptake inhibitors and after 4–6 weeks of therapy had complete resolution of symptoms. We conclude that serotonin reuptake inhibitors may be useful in the treatment of recurrent syncope due to carotid sinus hypersensitivity resistant to dual chamber cardiac pacing.     

Anomalous "VVI" Pacing of a Dual Chamber Pacemaker When Programmed in DDI(R) Mode

We describe the case of a dual chamber rate responsive pacemaker (Relay, model 294-03, Intermedics, Angleton, TX, USA) implanted in a 68-year-old male for sick sinus syndrome, which was not working properly when programmed in the DDIR mode, thus determining occasionally a sort of "VVI" pacing. However, the pacemaker performed well when programmed in the DDDR mode. We discovered that this was not a malfunction of a single device but rather a general behavior of this family of Intermedics dual chamber pacemakers (also not rate responsive), caused by a software problem.